StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Guided Therapeutics's enterprise value was $15.44M on Oct 19, 2026, against $21.17M a year earlier. Over the last 5 years it ranged from $5.12M to $45.09M, with a median of $8.93M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$15.44M-65.7%
2025Dec 31, 2025$45.09M+405.0%
2024Dec 31, 2024$8.93M+22.6%
2023Dec 29, 2023$7.28M+29.8%
2022Dec 30, 2022$5.61M-23.9%
2021Dec 31, 2021$7.37M–

More Guided Therapeutics figures

See a number that looks wrong?